LB Pharmaceuticals Inc Common Stock

LBRXNASDAQHealthcare● Active

$29.40

+$0.87(+3.05%)

Market Cap$843093569

P/E Ratio—

52W High$33.47

52W Low$13.36

Avg Volume236K

Open$28.84

Beta0.71

Cash on Hand Financials Revenue

LB Pharmaceuticals Inc Common Stock (LBRX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

LBRX · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$295.2M▲ +954.4% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$250.2M

cashAndCashEquivalents

Short-Term Investments

$45.0M

shortTermInvestments

YoY Change vs Prior Year

+954.4%

vs prior fiscal year

Latest Quarter

$365.6M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$295.2MCash on Hand

Total Debt$3.6MTotal Debt

Net Cash / Net Debt+$291.6MNet Cash Position

Cash vs Debt Ratio

Cash 99%LB Pharmaceuticals Inc Common Stock cash as % of market cap: 35.02%% · MCap $1BDebt 1%

LB Pharmaceuticals Inc Common Stock has a net cash position of $291.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$295.2M − $3.6M = +$291.6M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

LBRX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

LBRX cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$295.2M+954.4%

Dec 31, 2024FY$28.0M-35.3%

Dec 31, 2023FY$43.3M+102.3%

Dec 31, 2022FY$21.4M—

LBRX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

LBRX vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

LB Pharmaceuticals Inc Common StockYOU

LBRX

$295.2M$835M35.4%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

LB Pharmaceuticals Inc Common Stock (LBRX) cash on hand as of December 31, 2025 is $295.2M, comprising $250.2M in cash and cash equivalents (CCE) plus $45.0M in short-term investments — reported as LB Pharmaceuticals Inc Common Stock cash and short-term investments on the balance sheet (10-K filing). Also referred to as LB Pharmaceuticals Inc Common Stock cash reserves or cash position.

LB Pharmaceuticals Inc Common Stock annual cash on hand history shows increased +954.4% in 2025: increased +954.4% in 2025. LB Pharmaceuticals Inc Common Stock cash reserves in 2025 reflect the company's capital allocation strategy.

LB Pharmaceuticals Inc Common Stock carries total debt of $3.6M against cash of $295.2M, resulting in a net cash position of +$291.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

LBRX cash on hand · 5 questions

As of December 31, 2025, LB Pharmaceuticals Inc Common Stock (LBRX) has $295,213,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $250,173,000 in cash and cash equivalents (CCE) plus $45,040,000 in short-term investments. Latest quarter (March 31, 2026): $365,636,000. Data sourced from the annual 10-K filing via FMP.

LBRX cash on handLBRX cash reservesLBRX cash 2025how much cash does LBRX have

▸ Source: FMP /balance-sheet-statement · US GAAP · LB Pharmaceuticals Inc Common Stock · LB Pharmaceuticals Inc Common Stock SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025